一圖看懂景瑞控股(1862.HK)2021全年業績
近日,景瑞控股(1862.HK)公佈了2021全年未審計業績,集團實現營收人民幣135.5億元,同比增長6.0%;合約銷售為人民幣270.1億元,同比增長5.9%;毛利為人民幣24.4億元,毛利率為18.0%;總土儲為498.9萬平方米,新獲7個項目;三條賽道中物業實現收入增長37.4%至人民幣7.23億元,不動產克服疫情出租率提升;三條紅線持續保持綠檔,實現了2021全年的穩健發展。
具體業績如何將以一圖帶您看懂。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.